Cargando…
A Review: Proteomics in Nasopharyngeal Carcinoma
Although radiotherapy is generally effective in the treatment of major nasopharyngeal carcinoma (NPC), this treatment still makes approximately 20% of patients radioresistant. Therefore, the identification of blood or biopsy biomarkers that can predict the treatment response to radioresistance and t...
Autores principales: | Chen, Ze-Tan, Liang, Zhong-Guo, Zhu, Xiao-Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519910/ https://www.ncbi.nlm.nih.gov/pubmed/26184160 http://dx.doi.org/10.3390/ijms160715497 |
Ejemplares similares
-
Mitochondrial proteomics of nasopharyngeal carcinoma metastasis
por: Liu, Jianping, et al.
Publicado: (2012) -
A Comprehensive Review on Radiomics and Deep Learning for Nasopharyngeal Carcinoma Imaging
por: Li, Song, et al.
Publicado: (2021) -
Serum CD166: A novel biomarker for predicting nasopharyngeal carcinoma response to radiotherapy
por: Lin, Huan, et al.
Publicado: (2017) -
Role of chemotherapy in stage IIb nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2012) -
A Systematic Review and Meta-Analysis of Studies Comparing Concurrent Chemoradiotherapy With Radiotherapy Alone in the Treatment of Stage II Nasopharyngeal Carcinoma
por: Xu, Yao-Can, et al.
Publicado: (2022)